Pre-treatment expression data from neoadjuvant platinum & bevacizumab treated triple negative breast cancer patients

ABSTRACT: Gene expression data from 21 triple negative breast cancer samples treated with cisplatin & bevacizumab in the neoadjuvant setting as part of a clinical trial. Gene expression data RMA normalized was used to find predictors of platinum sensitivity

ORGANISM(S): Homo sapiens

PROVIDER: GSE103668 | GEO | 2018/02/19

REPOSITORIES: GEO